Participated · Series A · Jul 2026

Founded in 2024 and headquartered in Santa Clara, ChipAgents develops an AI-native platform that applies domain-specific autonomous agents to semiconductor design and verification. Its agents transform specifications and code into production-ready RTL and verification assets and perform automated root-cause analysis, claiming to reduce design cycles by over 50% and compress tasks that once took months into days or hours. The company reported rapid commercial adoption, with deployments at more than 120 semiconductor companies including MediaTek and Micron and 6x ARR growth in the first half of 2026. ChipAgents positions its technology as moving beyond AI copilots to agents that can independently plan and execute multi-step engineering workflows. The company plans to use recent funding to scale customer deployments, expand engineering and go-to-market headcount, and accelerate product development to meet rising global demand.

Participated · Series A · Jul 2026

Flourish Health delivers intensive in-home mental health care for children and young adults through psychiatrist-led Care Pods composed of a child and adolescent psychiatrist, a licensed therapist, a patient guide, and a family guide. The company built a proprietary technology platform that integrates patient touchpoints, EMR and prescribing capabilities, workflow automation, team collaboration, and AI to support engagement and coordination while clinicians make clinical decisions. Flourish specializes in three clinical populations: children with externalizing behaviors, young people with multiple suicide attempts or suicide-related hospitalizations, and patients with complex needs and family situations often turned away by other clinics. Studies run with multiple major health plans report large reductions in hospitalization (70–96%), residential treatment (69–90%), and sustained decreases in higher levels of care post-discharge (80–95%). Flourish commits to beginning care within one week of referral, reports 92% month-over-month retention during its 12-month programs, and says those programs cost less than one month of inpatient treatment.

Led · Seed · Jun 2026

Seltz builds a purpose-built search stack—owning its web crawler, index, retrieval models, and ranking—targeted at AI agents and chatbots that require machine-ready, citable information. The system crawls hundreds of millions of pages per day, returns results in under 200 milliseconds, and scores and extracts specific passages, tables, or images to supply agents rather than just human-oriented snippets. Founder and CEO Antonio Mallia previously worked on information retrieval in his PhD and at Amazon and Pinecone, and the team includes multiple PhD holders and veterans of Amazon’s AI efforts. Seltz was incorporated in the U.S. and founded last October, operates fully remotely with about 15 employees split between the San Francisco Bay Area and hubs near European universities in Pisa and Leipzig. The company faces a crowded competitive landscape with better-funded peers, but plans to use its seed funding to advance its search stack, hire, and launch enterprise sales. Its advisers and angel backers span technology companies and academic information-retrieval labs.

Participated · Series C · Jun 2026

Cadence Solutions builds Clinical Intelligence that monitors patients with chronic disease, surfaces risks, and coordinates actions through supervised AI agents integrated into health systems' EMRs and workflows. The company works alongside more than 20 leading health systems and currently treats over 100,000 active patients. Peer-reviewed studies and real-world deployments cited in the company's materials show validated outcomes, including a 230% increase in heart-failure patients on guideline-directed medical therapy, a 70% relative increase in blood-pressure control for hypertension patients, a 27% reduction in hospital admissions, and a $1,302 per-patient annual reduction in total cost of care. Cadence reported it saves Medicare roughly $2.7 million every week and that its model returns more than $3 to Medicare for every dollar spent. Commercial traction includes tripling annual recurring revenue in 2025 and new affiliations with Duke Health and Texas Health Resources. With the Series C capital, Cadence plans to accelerate expansion into additional health systems, further develop its AI agents, and scale value-based care deployments.

Led · Equity · Jun 2026

Yalo builds conversational commerce and customer-engagement tools that let businesses automate customer service, sales, collections and billing through WhatsApp. The company focuses on enabling companies in Latin America to use WhatsApp as a primary digital channel for consumer interactions. With the new $50 million financing led by B Capital, Yalo intends to accelerate development of AI-driven features for its platform. The announcement emphasizes growth of the company’s AI capabilities and commercial offerings; no revenues, user counts, or valuation were disclosed in the report.